L
Lingling Tang
Researcher at Zhejiang University
Publications - 18
Citations - 548
Lingling Tang is an academic researcher from Zhejiang University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 11 publications receiving 310 citations.
Papers
More filters
Journal ArticleDOI
Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment
Jiajia Chen,Chenxia Hu,Lijun Chen,Lingling Tang,Yixin Zhu,Xiaowei Xu,Lu Chen,Hainv Gao,Xiaoqing Lu,Liang Yu,Xiahong Dai,Charlie Xiang,Lanjuan Li +12 more
TL;DR: It is suggested that MSCs significantly improve the survival rate of H7N9-induced ARDS and provide a theoretical basis for the treatment of H6N9 and the corona virus disease 2019 (COVID-19) in both preclinical research and clinical studies.
Journal ArticleDOI
Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity
Lingling Tang,Silan Gu,Yiwen Gong,Bo Li,Haifeng Lu,Qiang Li,Ruhong Zhang,Xiang Gao,Zhengjie Wu,Jiaying Zhang,Yuanyuan Zhang,Lanjuan Li +11 more
TL;DR: The results indicated that dysbiosis occurred in COVID-19 patients and changes in the gut microbial community were associated with disease severity and hematological parameters, and that the Ec/E ratio can be used to predict death in critically ill patients.
Journal ArticleDOI
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19.
Lingling Tang,Yingan Jiang,Mengfei Zhu,Lijun Chen,Xiaoyang Zhou,Chenliang Zhou,Peng Ye,Xiaobei Chen,Baohong Wang,Zhenyu Xu,Qiang Zhang,Xiaowei Xu,Hainv Gao,Xiaojun Wu,Dong Li,Wanli Jiang,Jingjing Qu,Charlie Xiang,Lanjuan Li +18 more
TL;DR: Results indicated that MSC transplantation provides clinical data on the treatment of CO VID-19 and may serve as an alternative method for treating COVID-19, particularly in patients with ARDS.
Journal ArticleDOI
Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) Virus
Shufa Zheng,Lingling Tang,Hainv Gao,Yiyin Wang,Fei Yu,Dawei Cui,Guoliang Xie,Xianzhi Yang,Wen Zhang,Xianfei Ye,Zi-Ke Zhang,Xi Wang,Liang Yu,Yiming Zhang,Shigui Yang,Weifeng Liang,Yu Chen,Lanjuan Li +17 more
TL;DR: Early NAI therapy within 2 days of illness shortened the duration of viral shedding and improved survival in patients with H7N9 viral infection.
Journal ArticleDOI
Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study.
Yan Zhang,Hainv Gao,Weifeng Liang,Lingling Tang,Yida Yang,Xiaoxin Wu,Liang Yu,Ping Chen,Shufa Zheng,Huilin Ou,Lanjuan Li +10 more
TL;DR: The results suggest that in adults with H7N9 virus infection, the use of oseltamivir-peramivirs combination therapy was not superior to oselTamivIR monotherapy.